Q: Would like your review of results. Do you think this is a good entry point for a 5 year hold and what return can I reasonably expect over 5 years, Thanks John
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Good morning guys :
Do u agree with Mr donvilles assessment for this this name as potentially being the next great growth stock . Would u buy here at its current price and throw it in a tfsa for many years .
Thx
Mark
Do u agree with Mr donvilles assessment for this this name as potentially being the next great growth stock . Would u buy here at its current price and throw it in a tfsa for many years .
Thx
Mark
-
Eli Lilly and Company (LLY $1,070.16)
-
UnitedHealth Group Incorporated (DE) (UNH $319.05)
-
Veeva Systems Inc. Class A (VEEV $235.74)
-
WELL Health Technologies Corp. (WELL $3.94)
Q: Hi Team,
Currently for healthcare exposure I own VEEV and WELL. I was considering replacing VEEV with either LLY or UNH. Would this be advisable? If so, which one would you recommend? Also, regarding Well would you recommend continuing to hold it; or selling it to make a switch for either LLY or UNH as well? What sort of mix here would you recommend? I am looking for long term growth here. Lastly...do you see the healthcare sector in general to be a good place to be right now?
Thanks,
Shane.
Currently for healthcare exposure I own VEEV and WELL. I was considering replacing VEEV with either LLY or UNH. Would this be advisable? If so, which one would you recommend? Also, regarding Well would you recommend continuing to hold it; or selling it to make a switch for either LLY or UNH as well? What sort of mix here would you recommend? I am looking for long term growth here. Lastly...do you see the healthcare sector in general to be a good place to be right now?
Thanks,
Shane.
-
Amgen Inc. (AMGN $334.30)
-
Intuitive Surgical Inc. (ISRG $568.48)
-
AbbVie Inc. (ABBV $229.51)
-
Eli Lilly and Company (LLY $1,070.16)
-
Profound Medical Corp. (PRN $8.54)
Q: Good Morning, Can I please get your opinion on the recent earnings of Viemed and Profound Medical? Are they worth holding for several more quarters, or is it perhaps time to move on. I know you don't have many ideas for Canadian healthcare stocks, other than WELL (which I own), but if you wanted to switch to another CDN or US healthcare stock, what might you consider? Thanks. Brad
Q: Hi Peter,
What are Earnings (total $ amount and $/share estimates) and Revenue $ amount for Well in Q4.
Thank you
What are Earnings (total $ amount and $/share estimates) and Revenue $ amount for Well in Q4.
Thank you
-
UnitedHealth Group Incorporated (DE) (UNH $319.05)
-
Align Technology Inc. (ALGN $143.63)
-
Arch Capital Group Ltd. (ACGL $91.94)
-
Interactive Brokers Group Inc. (IBKR $62.43)
-
Elevance Health Inc. (ELV $329.60)
-
Fiserv Inc. (FISV)
Q: I am currently underweight Health and Financials in the U.S. Can you please provide your top 3-5 picks for each based on current valuations and considering a 5 year+ timeframe??
Q: LLY stock price is struggling lately. Do you have insight to the reasons for the drop? I am interested in a purchase but would like to avoid catching a falling knife. I would appreciate your insight. Thanks you.
-
Intuitive Surgical Inc. (ISRG $568.48)
-
AbbVie Inc. (ABBV $229.51)
-
Eli Lilly and Company (LLY $1,070.16)
-
UnitedHealth Group Incorporated (DE) (UNH $319.05)
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $71.03)
-
Novo Nordisk A/S (NVO $44.97)
Q: My healthcare sector is very low. I will buying for within my TFSA account and wonder if the ETF XHC would be good ? I can also buy 3 US healthcare companies as I would have enough funds to do so. What would be the best 3 US healthcare companies you would buy if this is preferred over the EFT?
Thanks
Thanks
Q: I have been having a hard time pulling the trigger on Eli Lilly.
It has doubled in the last year.
I know that it is recommended, but it looks potentially overvalued.
Does there long term financials justify the current price?
Should I continue to wait for a pullback, that may never come;)
It has doubled in the last year.
I know that it is recommended, but it looks potentially overvalued.
Does there long term financials justify the current price?
Should I continue to wait for a pullback, that may never come;)
Q: Please provide your view on Baxter and the significance of the spinout(or sale) of the kidney division. The stock has finally gained some traction after a tough few years. Do you like it as a position in a diversified USD account?
Q: Hello,
I wanted to discuss Pfizer, a company with a dividend yield of 6%. Its yield and growth prospects appear more appealing than those of many other dividend stocks, including those in the telecommunication and utility sectors.
My question is: What is your opinion on purchasing Pfizer as a dividend stock for my RRSP and waiting for its recovery? Do you anticipate that it will regain market momentum either this year or sometime next year?
Thank you for your insights!
I wanted to discuss Pfizer, a company with a dividend yield of 6%. Its yield and growth prospects appear more appealing than those of many other dividend stocks, including those in the telecommunication and utility sectors.
My question is: What is your opinion on purchasing Pfizer as a dividend stock for my RRSP and waiting for its recovery? Do you anticipate that it will regain market momentum either this year or sometime next year?
Thank you for your insights!
Q: LEXX on Nasdaq, Lexaria Bioscience Corp, do you have any insight on this company and why it is trending higher of late? Thanks.
Q: Hello,
Would Zoetis be a stock that you would recommend and if yes what would you suggest for an entry price?
Would Zoetis be a stock that you would recommend and if yes what would you suggest for an entry price?
Q: Hi - do you have a preference between these two drug distribution companies? If you would avoid both at this time, then that's fine too!
Q: PFE share price is at a low for the past 10 years. It has a low PE with an attractive dividend that pays while you wait. Is the growth profile really that bad that it should be falling out of bed? My suspicion is that in reverting to the mean following the Covid revenue burst the market has overshot and it is unduly punishing the stock. This would represent an excellent buying opportunity, no?
Q: Out of NVO and LLY, which one would own today over a 3-year period? What kind of gains can we expect over that period?
Q: Can you please comment on the recent quarter and thoughts on the company going forward?
Q: Please comment on earnings and future prospects. It is down by over 5 percent today?
Thanks
Thanks
Q: What are your thoughts on the portfolio diversification and growth potential of these securities? Thx!
Q: Would Zoetis be a company you would recommend and if yes what would you consider a good entry price?
Thank you
Thank you